Maraviroc

Maraviroc is an antiviral medication currently still under a patent owned by Pfizer. It is one of the antivirals that is recommended by the Front Line COVID-19 Critical Care Alliance (FLCCC) and Bruce Patterson's IncellDx for the treatment of Long COVID. Therefore, it may also be of use in treating ME/CFS.

Notable studies

 * 2022, Targeting the monocytic-endothelialplatelet axis with maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae - Targeting the Monocytic-Endothelial-Platelet Axis with Maraviroc and Pravastatin as a Therapeutic Option to Treat Long COVID/ Post-Acute Sequelae of COVID (PASC) - (Full text, preprint)